Real-time qPCR (Figure 5F) and western blotting (Figures 5G, H) analyses indicate a significant (AGS vs GES-1: P<0.005, SGC-7901 vs GES-1: P<0.005, HGC27 vs GES-1: P<0.01) lower expression level of IFIT2 in gastric cancer cells than in gastric epithelial cells. Here, IFIT2 is linked to gastric cancer.